China is shortly to implement a pilot consolidated, volume-based procurement program that looks likely to set the tone for drug pricing for years to come, and which is already creating worry within the pharma industry as official efforts to rein in rising drug and healthcare costs continue.
A total of 11 cities, including four 'megacities', will participate in the centralized bidding scheme, representing the bulk of the...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

